Literature DB >> 16406872

Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome.

Sten Holmäng1, Sonny L Johansson.   

Abstract

PURPOSE: Metachronous bilateral UUTTs are rare. The authors reported baseline and long-term followup data for all patients diagnosed in Western Sweden during a 28-year period.
MATERIALS AND METHODS: We performed a clinical and histopathological analysis of all patients in Western Sweden surgically treated for ureteral and renal pelvic tumors from 1971 to 1998.
RESULTS: Of 768 patients a contralateral UUTT developed in 24 (3.1%) after a median of 46 months (range 2 to 232). The projected incidence after initial UUTT diagnosis was 2.7%, 5.8% and 6.5% at 5, 10 and 15 years, respectively. Median age of the 24 patients at initial UUTT diagnosis was 67 years and the median age at death was 77 years. Bladder cancer was significantly more common among patients with bilateral UUTT compared to those with unilateral UUTT (83% vs 31%, p <0.0001). Routine followup urography was normal in 9 patients 2 to 11 months before the diagnosis of the contralateral UUTT. Nine patients died of UUTT and 5 patients died of bladder cancer.
CONCLUSIONS: Bilateral subsequent upper tract tumors are rare, in general diagnosed at an older age and associated with short survival. Many patients die of bladder cancer and it may be possible to improve survival if the bladder cancer is treated early and aggressively. Routine followup urography is not indicated among patients with a tumor-free bladder and a history of UUTT.

Entities:  

Mesh:

Year:  2006        PMID: 16406872     DOI: 10.1016/S0022-5347(05)00057-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center.

Authors:  Dong Fang; Lei Zhang; Xuesong Li; Gengyan Xiong; Xiaopeng Chen; Wenke Han; Zhisong He; Liqun Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-28       Impact factor: 4.553

2.  Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?

Authors:  Nessn H Azawi; Kasper Drimer Berg; Andreas Key Milan Thamsborg; Claus Dahl; Jan Viberg Jepsen; Bjarne Kroman-Andersen; Johan Poulsen; Helle Handler Petersen; L Henning Olsen; Jørgen Bjerggaard Jensen
Journal:  Int Urol Nephrol       Date:  2017-07-31       Impact factor: 2.370

3.  Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.

Authors:  Kathleen G Dickman; Chung-Hsin Chen; Arthur P Grollman; Yeong-Shiau Pu
Journal:  World J Urol       Date:  2022-07-22       Impact factor: 3.661

Review 4.  [Renal pelvic carcinoma: a different urothelial tumor?].

Authors:  F Hofstädter
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

5.  Prevalence, clinicopathological features, and prognosis in upper tract urinary carcinoma patients with severe preoperative chronic kidney disease.

Authors:  Zhengqing Bao; Yicong Du; Yiming Yuan; Yuze Zhu; Cheng Qian; Yonghao Zhan; Dong Fang; Gengyan Xiong; Lei Zhang; Xuesong Li; Liqun Zhou
Journal:  Transl Androl Urol       Date:  2019-12

6.  Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.

Authors:  Lei Zhang; Gengyan Xiong; Dong Fang; Xuesong Li; Jin Liu; Weimin Ci; Wei Zhao; Nirmish Singla; Zhisong He; Liqun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2015-01-22

7.  Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study.

Authors:  Tsu-Ming Chien; Hsiang-Ying Lee; Nirmish Singla; Vitaly Margulis; Yair Lotan; Solomon Lukasz Woldu; Chun-Nung Huang; Ching-Chia Li; Hung-Lung Ke; Wei-Ming Li; Chia-Yang Li; A-Mei Huang; Sheau-Fang Yang; Hung-Pin Tu; Wen-Jeng Wu; Hsin-Chih Yeh
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

8.  Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma.

Authors:  Claudio B Murta; Alberto A Antunes; Marcos F Dall'Oglio; Alcides Mosconi; Kátia R Leite; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

9.  Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma.

Authors:  Kan Wu; Jiayu Liang; Yiping Lu
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.